-
公开(公告)号:US10563285B2
公开(公告)日:2020-02-18
申请号:US15516623
申请日:2015-10-06
申请人: CONSTELLIUM ISSOIRE
发明人: Jean-Louis Achard , Pierre Le Brun
IPC分类号: G01N33/205 , C22B9/02 , B06B3/00 , C22B21/06 , G01N29/032 , G01N29/22
摘要: The method comprises the following steps: a) Providing a sonotrode (1) formed from an essentially inert material with respect to the liquid metal, such as a ceramic, and preferably a silicon nitride or a silicon oxynitride, such as SIALON, or a metal essentially inert to said liquid metal, b) Immersing at least partially the sonotrode (1) in a bath of said metal, c) Applying to the sonotrode (1) power ultrasounds, particularly ultrasounds having a power greater than 10 watts to obtain the wetting of said sonotrode by said metal, d) Applying continuously to the sonotrode (1) measurement ultrasounds, also known as testing ultrasounds, particularly ultrasounds wherein the frequency is between 1 and 25 MHz, e) Applying intermittently to the sonotrode (1) power ultrasounds, particularly ultrasounds having a power greater than 10 watts, to maintain said wetting.
-
公开(公告)号:US10537624B2
公开(公告)日:2020-01-21
申请号:US15461020
申请日:2017-03-16
发明人: Dominik Maurer , Leonie Alten , Sebastian Bunk
IPC分类号: C07K14/725 , A61K39/00 , A61K45/06 , G01N33/574
摘要: The present description relates to T-cell receptors (TCRs) binding to tumor-associated antigens (TAAs) for targeting cancer cells, T-cells expressing same, methods for producing same, and methods for treating cancers using same. In particular, the present description relates to TCRs and their variants that bind to HLA class I or II molecules with a peptide, such as IGF2BP3-001 have the amino acid sequence of KIQEILTQV (SEQ ID NO:1). The present description further relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present description relates to the immunotherapy of cancer. The present description furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T-cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
公开(公告)号:US10519516B2
公开(公告)日:2019-12-31
申请号:US15589039
申请日:2017-05-08
申请人: DSM IP ASSETS B.V.
摘要: The present invention relates to a kit suitable for detection of Streptococcus thermophilus infecting phages, said kit comprising: (a) a first primer pair suitable to generate an amplicon characteristic for a 987 phage; and (b) a second primer pair suitable to generate an amplicon characteristic for a 5093 phage. Further, the present invention relates to a method for detecting the presence of Streptococcus thermophilus infecting phages in a sample.
-
公开(公告)号:US10513496B2
公开(公告)日:2019-12-24
申请号:US15938900
申请日:2018-03-28
发明人: Ulrich Görgens , Akihiko Yanagi , Katsuaki Wada , Tetsuya Murata , Yukiyoshi Watanabe , Jun Mihara , Koichi Araki
IPC分类号: C07D213/60 , A01N37/46 , A01N43/08 , A01N43/10 , A01N43/40 , A01N43/56 , A01N43/82 , A01N47/20 , C07C237/42 , C07C271/28 , C07C317/44 , C07C323/62
摘要: The invention relates to a composition comprising at least one aminobenzamide compound or a salt thereof for controlling animal parasites, veterinary pharmaceutical compositions comprising at least one aminobenzamide of formula (I) for preventing infection with diseases transmitted through parasites, its use for the preparation of a veterinary pharmaceutical for controlling animal parasites, and a method for preventing infection with diseases transmitted through parasites.
-
公开(公告)号:US10512679B2
公开(公告)日:2019-12-24
申请号:US15458893
申请日:2017-03-14
发明人: Toni Weinschenk , Oliver Schoor , Andrea Mahr
IPC分类号: A61K38/00 , A61K39/00 , G16B25/00 , C07K14/47 , C07K14/725 , C07K16/18 , C07K16/28 , C12N5/0783 , C12N15/115 , C12Q1/6886 , G01N33/574 , G01N33/68 , C07K14/64 , C07K14/705 , C07K16/00
摘要: The present description relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present description relates to the immunotherapy of cancer. The present description further relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T-cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
公开(公告)号:US10479823B2
公开(公告)日:2019-11-19
申请号:US16152122
申请日:2018-10-04
发明人: Andrea Mahr , Toni Weinschenk , Oliver Schoor , Jens Fritsche , Harpreet Singh , Lea Stevermann
IPC分类号: C07K14/70 , C07K14/74 , G01N33/569 , A61K39/00 , C07K16/28 , A61K45/06 , C07K14/725 , C12Q1/6886 , C07K14/47 , C07K16/30 , A61K38/08 , C07K7/02 , C07K7/06 , G01N33/566 , C07K16/18 , C12N5/0783 , C12N9/64 , C07K14/00 , A61K38/17 , G01N33/50 , A61K38/06 , A61K38/00
摘要: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
公开(公告)号:US10458009B2
公开(公告)日:2019-10-29
申请号:US14400582
申请日:2013-05-15
发明人: Ravi Shahani , Lukasz Dolega , Ivo Kolarik
IPC分类号: C22C21/02 , C22C21/08 , C22F1/043 , C22F1/05 , C22F1/057 , B22D21/00 , C22C21/14 , C22C21/16 , C22F1/04 , C22F1/047 , F16D65/18 , F16D125/06 , C25D11/04 , C25D11/08
摘要: A wrought aluminium alloy product having the following chemical composition, expressed in wt %: 1.3%≤Si≤12%, 1.35%≤Fe≤1.8% wherein the total Fe+Si content is higher than 3.4%, preferably 3.6%; 0.15%≤Cu≤6%; 0.6%≤Mg≤3%; optionally, one or more of the following elements: Mn≤1%; Cr≤0.25%; Ni≤3%; Zn≤1%; Ti≤0.1%; Bi≤0.7%; In≤0.7%; Sn≤0.7%; other elements
-
公开(公告)号:US10457890B2
公开(公告)日:2019-10-29
申请号:US15564275
申请日:2016-04-08
申请人: DSM IP ASSETS B.V.
发明人: Arjen Sein , Rene Marcel De Jong , Evert Tjeerd Van Rij , Willem Bijleveld , Maarten Hotse Wilbrink
摘要: The present invention relates to a polypeptide having phospholipase C activity, selected from the group consisting of i. a polypeptide comprising a mature polypeptide sequence of SEQ ID NO: 2; ii. a polypeptide that has least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity to the mature polypeptide sequence of SEQ ID NO: 2; iii. a polypeptide encoded by a nucleic acid that hybridizes under medium stringency, preferably under high stringency conditions to the complementary strand of the mature polypeptide coding sequence of SEQ ID NO:1; iv. a polypeptide encoded by a nucleic acid that has at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% identity to the mature polypeptide coding sequence of SEQ ID NO: 1. A process for degumming a vegetable oil comprising contacting a vegetable oil comprising phospholipids with a polypeptide having phospholipase C activity of the invention or a composition of the invention, wherein phospholipids are hydrolyzed into diacylglycerol and phosphate ester and/or phosphate, separating the phosphate ester and/or phosphate from the vegetable oil wherein a degummed vegetable oil is obtained.
-
公开(公告)号:US10449238B2
公开(公告)日:2019-10-22
申请号:US16385221
申请日:2019-04-16
发明人: Andrea Mahr , Toni Weinschenk , Oliver Schoor , Jens Fritsche , Harpreet Singh , Phillip Mueller , Julia Leibold , Valentina Goldfinger
IPC分类号: A61K38/00 , A61K39/00 , G01N33/574 , C12Q1/6886 , C12N5/0783 , C07K16/30 , C07K14/47 , C12N15/115 , C07K14/725 , G01N33/68
摘要: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
公开(公告)号:US10440952B2
公开(公告)日:2019-10-15
申请号:US16069242
申请日:2017-01-12
发明人: Rachel Baltz , David Bernier , Florence Jay-Brioudes , Thomas Knobloch , Maxime Vitel , Olivier Voinnet
IPC分类号: A01N43/80 , A01G7/06 , C07D261/12 , C07D409/06 , A01G22/60 , A01G22/50 , A01G22/05 , A01G17/02 , A01G23/00
摘要: The present invention relates to the use of specific active substances, alone or in combination, for controlling virus infections in plants and to a method for using said specific active substances for controlling said virus infections in the field of plant protection and the protection of materials.
-
-
-
-
-
-
-
-
-